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Volume-dependent inappropriate ADH secretion. R. A. Bear, J.
Drummond, and M. L. Halperin. Univ. of Toronto, Toronto,
Canada. We investigated a 56-year-old woman for chronic hypo-
natremia. There was a distant history of skull fracture. She took
no medications. Physical examination was normal. Serum Na
was 128 mEq/liter; plasma osmolality was 265 mOsm/kg; urine
osmolality was high; and plasma ADH was elevated. Renal, ad-
renal and thyroid function was normal. Urinary dilution did not
occur following a standard water load, but only after i.v. Dilantin
(double i.v. and oral water loads and an oral water load along
with an i.v. saline load). Urinary dilution occurred despite rising
plasma osmolality after a double water load and 400 cc of hyper-
tonic saline i.v. Serum Na and urine osmolality responded nor-
mally to water deprivation. In this patient, inappropriate ADH
release could be suppressed by volume expansion but not by-
poosmolality.
Malakoplakia secondary to immunosuppression. W. D. Biggar,
A. Keating, andR. A. Bear. Univ. of Toronto, Toronto, Canada.
A 50-year-old man was maintained on prednisone and azathio-
prine following renal transplantation. One year after trans-
plantation, he developed a lung and multiple perianal Esche-
richia coli abscesses. These became chronic and resisted antibi-
otic therapy. Histologically, the bronchial and perianal lesions
were typical of malakoplakia. Peripheral blood neutrophils and
monocytes had impaired killing of Staphylococcus aureus and E.
coli in vitro. No abnormality of hexose monophosphate pathway
activity, tetrazolium dye reduction, lysosomal degranulation, or
cyclic nucleotides could be demonstrated in either neutrophils or
monocytes. Cholinergic agonists in vitro and in vivo did not im-
prove bacterial killing by these cells. The infection resolved rap-
idly and bacterial killing returned to normal when the dose of
azathioprine was reduced. Our findings, when considered with
previous reports, suggest that there are different causes of ma-
lakoplakia and malakoplakia may be more common than pre-
viously thought. The etiology of malakoplakia should be identi-
fied for each patient if appropriate treatment is to be given.
Effect of converting enzyme inhibition by captopril on reno-
vascular responses during hemorrhagic hypotension in the dog. H.
Canos and H. Fung. Dept. of Medicine, Univ. of Manitoba,
Winnipeg, Manitoba. Renovascular response to graded hemor-
rhagic hypotension (HH) and reinfusion (RI) of shed blood was
studied in 3 groups of mongrel dogs. Graded HH was produced
by bleeding 27 mI/kg over 80 mm (eight 10-mm intervals). Hy-
povolemia was maintamne4 for an additional 2.5 hours. Shed
blood was reinfused in a similar graded fasion. RBF was mea-
sured using EM flowmeters, Group 1 (N = 7) served as the con-
trol. In group 2 (N = 8), captopril (C) (1 mg/kg i.v.) was given
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before hemorrhage (pre-H), and supplemental doses were given
post-H and pre-RI. In group 3 (N = 4), C was given post-H and
pre-RI.
BP,% RBF,% RVR,%
Post-H Up 1
Gp2
Gp3
77.3
59.7
69.4
67.3
60.5
68.8
117.4
105.2
111.7
Pre-RI Gp 1
Gp2
Up 3
72.3
57.7
59.7
44.4
84.2
86.7
263.6
78.5
94.8
Post-RI Gp 1
Gp2
Up 3
87.0
77.7
88.3
71.0
123.9
108.6
137.1
70.1
87.5
(Data represent group means expressed as a percentage of the
pre-H value.) Persistent renal vasoconstriction occurred follow-
ing prolonged HH and was not abolished with RI. However, in
spite of lower BP, C given either pre-H or post-H resulted in
higher RBF and lower RVR. Persistent renal vasoconstriction
was abolished. Saralasin treatment resulted in similar hemo-
dynamic changes. These findings suggest that the renin-angioten-
sin system plays a major role in mediating renal vasoconstriction
during HH.
Preliminary results of controlled trial of alternate-day predni-
sone in idiopathic membranous glomerulonephritis. D. Cattran,
C. Cardella, R. Charron, J. Roscue, P. Rance, M. Cusimano, R.
Bear, M. Johnson, and P. Corey. Univ. of Toronto, Toronto,
Ontario. Seventy-two patients (28 treatment, 44 control) have
been entered into a randomized prospective trial to assess the
effects on renal function of 45 mg/rn2 of prednisone (group D)
given for 6 months vs. no specific treatment (group C). Patients
were stratified by (1) pathology into stages 1, 2, 3, and 4; and (2)
whether their initial corrected creatinine clearance was smaller
or larger than 90 mI/mm. Secondary causes were ruled out. One
patient on D withdrew (peptic ulceration). Mean age and range in
group D was 38 (7 to 82) and in C, 41 (4 to 77). Initial creatinine
(Cr) was the same in D (1.2 mg/dl) and C (1.17 mgldl). Sex distri-
bution was: 43 males and 29 females. Change in mean Cr/year
was:
Followup
Group Stage 1,2 Stage 3,4 days
D —0.08
(N= 17)
+0.07
(N= 11)
623
P<0.02 P=NS
C +0.34
(N=29)
+0.24
(N= 15)
618
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Proteinuria
Normalized
Group
Stage
1,2 3,4
<50%
1,2
Initial
3,4
No response
1,2 3,4
D 8% 14% 33% 28% 58% 57%
C 31% 8% 24% 8% 44% 83%
Preliminary data suggests at least a short-term benefit of predni-
sone in stage 1 and 2 in idiopathic membranous glomerulonephri-
tis in preservation of GFR. Effects of proteinuria were not signif-
kant. Minimal side effects occur on this regimen.
Cyclophosphamide effects on experimental autologous immune
complex glomerulonephritis. D. C. Cattran, D. Man, W. Chodir-
ker. University of Toronto and Western Ontario, Toronto, On-
tario, Canada. Single shot autologous immune complex glomer-
ulonephritis (AICGN) was induced in male Wistar rats using 3
mg of human renal tubular epithelial antigen (Ag). One group
received only Ag (C), others received Ag plus cyclophosphamide
(CY), 10, 100 or 300mg 2 days before (DB), day of antigen (DO),
and 2 and 7 days after (DA) Ag (8 rats each group). The rats' sera
was monitored for: (1) circulating antibody (Ab) by indirect im-
munofluorescence (hF) and hemagglutination (HA), (2) free Ag
(immunodiffusion against purified rabbit IgG anti Ag) (3) circulat-
ing immune complexes (CIC) (Clq solid phase binding assay). As
well, periodic renal biopsies were taken for light, IF, and elec-
tron microscopy. No free Ag was found in any group after 15
days. Free Ab was found by 20 days in C and all 10-mg CY
groups with subsequent IC seen in a granular pattern on GBM
and around tubules by day 30. High Ab titers persisted; granular-
ity and proteinuria was noted by day 90 to 120. The 300-mg CY
group did not develop a significant Ab titer until > 40 to 60 days,
and renal tissue showed absence of IC deposits on GBM by IF
and EM. The 200-mg CY group was variable. Circulating IC's
were never detected. (Positive control was heat aggregated rat
IgG; > 95% binding.) The absence of CIC and presence of high
free Ab titer suggest the model progresses in a state of antibody
excess. The disease is aborted by high-dose CY even given 7 DA
the inciting antigen.
Kidney stone analysis by infrared speetroscopy as a predictor of
urine chemistry. D. N. Churchill, J. Morgan, D. Dow, and M. H.
Gault. Faculty of Medicine, Memorial University of New-
foundland, St. John's, Newfoundland. The calcium oxa-
late:calcium phosphate ratio (0 : P) in a kidney stone can be
determined by infrared spectroscopy (IR). We have studied the
relationship between 0 : P of stones from 30 males taking no
diuretics and the urinary excretion of calcium,, oxalate, phos-
phate, expressed as mg/day, mg/g creatinine, and mg/liter. Two
consecutive urine collections were obtained at home with no
dietary restriction. 0 : P ranged from 0.05 to 50 (median 15.4);
weights from 1 to 1425 mg (median, 23.5 mg). There was no sig-
nificant correlation between the ratio and stone weight (r = 0.23;
p > 0.10). There was a significant correlation of 0 : P with 24-hr
urinary phosphate (r = —0.41;P < 0.05) and calcium (r = 0.41; P
<0.05) but not with oxalate (P> 0.05). When expressed as uri-
nary excretion/g creatinine or as mg/liter urine, the value for r
was significantly changed only for phosphate expressed as mg/
liter (r =
—0.43; P < 0.02). Stepwise multiple regression with 0:
P as the dependant variable and 24-hr urinary excretions of oxa-
late, phosphate, and calcium as independant variables showed
that the best explainer of variation was 24-hr urine calcium
(15.9%) whereas phosphate explained 12.3%. The 0 : P ratio in
calcium containing stones has a significant correlation with 24-hr
urine calcium and phosphate excretion. There was no significant
correlation with urinary oxalate excretion.
Monthly plasmapheresis in the treatment of systemic lupus ery-
thematosus with diffuse proliferative glomerulonephritis: A pilot
study. W. F. Clark, R. M. Lindsay, D. C. Cattran, W. B. Chodir-
ker, C. C. Barnes, J. J. Koval, and A. L. Linton. Department of
Medicine, University of Western Ontario and Victoria Hospital,
London, Ontario, Canada; University of Toronto and Toronto
General Hospital, Toronto, Ontario, Canada; McMaster Uni-
versity Medical School and St. Joseph's Hospital, Hamilton,
Ontario, Canada. Fourteen patients with systemic lupus cry-
thematosus and biopsy-proven diffuse proliferative glomerulone-
phritis were randomly allocated to a control group receiving con-
ventional therapy only, or to a treatment group who received
conventional therapy together with one 4-liter plasma exchange
monthly. The seven patients in the group treated by plasmaphe-
resis have shown a reduction in disease activity, steroid and
azathioprine therapy, and fewer admissions to hospital. As well,
patients in the plasmapheresis group have demonstrated a better
preservation of renal function as measured by serum creatinine
and creatinine clearance than the seven control patients. Those
receiving monthly elective plasma exchange also demonstrated a
reduction in evidence of immunologic activity as measured by
total complement, complement fragments, DNA binding, and
Clq binding and experienced no side-effects attributable to their
plasma exchanges. These data suggest that monthly plasma ex-
change should be assessed as a new therapeutic approach to pa-
tients with systemic lupus erythematosus and diffuse prolifera-
tive glomerulonephritis.
Renal adaptation to chronic metabolic acidosis in the chicken. A.
G. Craan, G. Lemieux, P. Vinay, andA. Gougoux. Renal Labo-
ratory, Hótel-Dieu Hospital and Dept. of Medicine, University
of Montreal, Montreal, Quebec. Renal adaptation to chronic
metabolic acidosis was studied in Arbor Acre hens weighing be-
tween 2.0 and 2.7 kg. The birds received NH4CI by stomach tube
0.75 g/kg/day during 6 days. At the end of this period plasma
bicarbonate had fallen from 19.7 to 10.0 mmoles/liter. The
unanesthetized animals were infused i.v. with an isosmotic mix-
ture of mannitol and saline. The ureters were catheterized after
fluidization of urine and tied securely to the cloacal mucosa. The
urine was collected in 20-mm periods. The results were com-
pared to those found in normal hens. In the acidotic birds, uri-
nary pH averaged 5.79 versus 6.46 in the normals. Ammonium
ion (NH4) excretion averaged 3.8 moles/min in contrast to 1.8
in the normals. When this value was corrected for the fall in renal
hemodynamics observed during acidosis, ammonium excretion
averaged 8.9 moles/min. Arterial blood glutamine was 0.51
moles/ml in the acidotic birds and 0.27 in the normals. Renal
tissue glutaminase I and glutamate dehydrogenase (GLDH) rose
significantly in the acidotic birds. Phosphoenolpyruvate carbox-
ykinase (PEPCK), which was located both in the mitochondria
and the cytosol, was not different in acidotic and normal hens.
Glutamine synthetase was virtually absent from the renal tissue.
The present data demonstrate that the kidney of birds adapts to
chronic metabolic acidosis. This adaptation is enzymatically dif-
ferent from that seen in either rat or dog. However, it is closer to
that observed in the rat.
Cyclosporin A: Mechanisms of immunosuppression. G. L. Es-
sery, C. R. Stiller, P. A. Keown, R. Mullen, N. R. Sinclair, and
R. A. Ulan. Department of Medicine, University Hospital, Lon-
don, Ontario. Cyclosporin A (CyA) is a potent immunosuppres-
sive agent with major potential application in the field of human
organ transplantation. In parallel with an ongoing clinical trial of
CyA in human renal transplant recipients, we have investigated
its effect at a cellular level on the immune response by means of
mixed lymphocyte culture (MLC), cytotoxic T-lymphocyte
(CTL) generation, cell-mediated lympholysis (CML), and direct
in vivo generated lymphocyte mediated cytotoxicity (LMC).
CyA (100 to 500 ng/ml) induced a marked suppression of MLC
and complete inhibition of CTL generation. This effect was both
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dose dependent (ID50 200 ng/ml) and time dependent, maximally
evident when CyA was present at the time of allogeneic stimula-
tion. CyA appears to induce permanent unresponsiveness to the
initial stimulator in vitro which is independent of the continuing
presence of the agent: restimulation studies using multiple stimu-
lator/target populations revealed diminished responsiveness to
an unrelated third party in secondary culture, suggesting the in-
duction of partially specific immunological unresponsiveness.
CyA inhibited the development of an anamnestic response and
CTL generation in vitro following primary sensitization in vivo
by allogeneic kidney transplantation. CTL, when generated in
vitro or in vivo, however, remained completely refractory to
CyA suppression. Conclusion. (1) CyA suppresses both cellular
proliferation and CTL generation following allogeneic stimula-
tion. (2) CyA induces permanent unresponsiveness to the initial
stimulator. (3) CTL, once generated, are refractory to CyA.
Enhanced urinary prostaglandin E2 in postobstructive diuresis
in humans. Y. Fradet, J. Sirnard, J. H. Grose, and M. Lebel.
Services of Nephrology and Urology, Hôtel-Dieu de Québec and
University of Lava!, Québec. To investigate the role of prosta-
glandins (PGs) in postobstructive diuresis, we measured urinary
PGs in three patients presenting mild postobstructive diuresis.
The obstruction in case 1 (male, 64 yr) was secondary to chronic
bladder outlet obstruction and in cases 2 and 3 (male, 61 yr; fe-
male, 36 yr), secondary to bilateral ureteral occlusion by in-
vading carcinoma. Serum creatinine levels were 3.7, 7.6, and
15.8 mg/dl, respectively. Urine was collected during the 4-day
postobstructive period. PGE2 and PGF2,. were measured by spe-
cific RIA after sample extraction and column chromatography.
Nonnal values for PGE2 are 462 48 (male) and 268 42 ng/day
(female). After relief of obstruction, urinary PGE2 ng/day volume
(V) was excessively elevated in the three cases.
Case 1 Case 2 Case 3
Day V,ml PGE2,ng V,ml PGE2,ng V,ml PGE2,ng
1 4157 2589 4519 5007 4519 5729
2 3060 2313 3056 7988 1980 4216
3 2933 1847 3705 10528 1840 4432
4 2284 2017 2200 3814 2774 3814
PGF2, remained within normal ranges in case 1, slightly elevated
in case 3, and 3 times the normal in case 2. Serum creatinine
normalized within 2 to 3 days in each case. These data suggest
that the increase in renal PGE2 after relief of chronic urinary ob-
struction could partially account for some of the tubular dysfunc-
tions.
Relationship of early posttransplant blood transfusions and re-
jection episodes in renal allograft recipients. D. Frei, R. D.
Guttmann, D. D. Morehouse, J. Meakins, C. Milne. Transpi.
Serv., Royal Victoria Hosp. and McGill University, Montréal.
The purpose of this study was to determine whether or not blood
transfusions given posttransplant have any adverse influence on
the severity and reversibility of rejection episodes. One hundred
seventy-two recipients of first allografts (124 nonliving donor re-
cipients and 48 living related donor recipients) were classified
according to whether or not they had received blood transfusions
for medical reasons either during transplant surgery (OR) and/or
at any time during the early post-transplant period. In each
group, the number of subsequent rejection episodes within a 6-
week period was evaluated, and the rejections were classified as
reversible or irreversible, The same evaluation was done for the
124 nonliving donor recipients as a subgroup. The summarized
results of the latter group are as follows:
Of 27 rej. in the transfused group, 3 (11%) were irreversible, and
15 of 62 rej. (24%) in the nontransfused group were irreversible.
In conclusion, recipients of nonliving donor and living donor al-
lografts show the same relationship between blood transfusions
and subsequent rejection episodes. No evidence was found to
suggest that posttransplant blood transfusions trigger rej. epi-
sodes or induce more severe rej. crises. Rej. episodes occur with
similar frequency in post-transplant transfused and in non-
transfused recipients although more irreversible rejections were
found in the nontransfused group.
Transfused Nontransfused
No. rej. 27(64%) 62(76%)
No. no rej. 15(36%) 20(24%)
Comparison of Redy and single-pass dialysis. H. Gault, J. Chal-
ker, B. Ryan, A. Fine, andD. Churchill. Dialysis Unit General
Hospital, and Memorial University. St. John's, Newfoundland.
Dramatic improvement in energy and strength was seen in two
patients within 2 weeks when switched to a single-pass (SP) sys-
tem after being on Redy (R) sorbent dialysis, one for 33 months
and the other for 17. This led us to make a retrospective cross-
over type analysis of clinical and laboratory data, in these and
the two other patients who had each been treated for at least 6
months on both R and SP. The most recent 6-month periods on R
and SP were used for analysis. Two patients crossed from R to
SF and two from SP to R. Total dialysis time ranged from 3 to 5
years. Urine output was < 100 mI/day in all patients. Dialysis
was performed for 5 hr, three times a week, by using 1 .5m2 dia-
lyzers with blood flow of 200 mI/mm. D32 cartridges were used
for the three men and a D3 1 for the woman without ammonia
breakthrough. Dialysate flow rate was 500 mI/mm for SP and 200
mi/mm for R. At least 14 values taken at intervals of 1 or more
weeks were available for all 15 parameters studied for each 6-
month R and SP period. Mean values were significantly greater
(P < 0.05 to < 0.001) on R compared with SP for plasma anion
gap in three patients, urea nitrogen in three, alkaline phosphatase
in three, and inorganic phosphorus in one. Plasma chloride was
lower in two patients (P < 0.001). No significant difference was
found in Na, K, C02, Ca, albumin, creatinine, uric acid, hemato-
crit, BP, and body weight. There may be a syndrome of weak-
ness and fatigue which develops in some patients after months on
Redy dialysis and responds quickly to single pass dialysis. Clear-
ances of a number of substances appear to be inferior with the
Redy sorbent system.
Autoantibody against fibroblasts in renal transplant recipients.
P. Halloran, M. Aprile, G. Haddad, S. Farkas, and M. Robin-
ette. Mount Sinai and Toronto General Hospitals, Toronto, On-
tario. While monitoring alloantibody responses in renal trans-
plant recipients, we found a strikingly high incidence of autore-
activity of patient sera against their own fibroblasts. Using
complement-dependent cytotoxicity (CDC), we detected activity
against autologous fibroblasts significantly more frequently (27%
of all sera, 24/51 patients) than against autologous lymphoid cells
(6% of sera, 10/54 patients). This autoreactivity was complement
dependent, absorbable by fibroblasts, 2 mercaptoethanol sensi-
tive, and usually not detectable in ADCC. Positive indirect im-
munotluorescence with autologous cells was demonstrable with
certain sera. No evidence that this antigen was coded by HLA
was observed. The stimulus for autoantibody formation was not
clear: normal sera had few reactions of this type, while patients'
scm were sometimes positive pretransplant and sometimes be-
came positive posttransplant. The presence of autoreactivity did
not seem to influence transplant outcome. We conclude that
many renal transplant patients have or develop autoantibodies,
possibly of the 1gM class, against a fibroblast-associated antigen.
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Ia in mouse kidney: Expression of marrow-derived and non-
marrow-derived cells. P. Halloran, S. Stylianos, M. Stubbs.
Mount Sinai Hospital, Toronto, Ontario. Because of the poten-
tial importance of the human Ia-like DR antigens in trans-
plantation, we investigated the characteristics of Ia antigens in
mouse kidney. Ia was readily detectable in crude mouse kidney
preparations by sensitive absorption techniques. Many types of
preparation (enzyme digestions, seiving, sonication, and combi-
nations of these techniques) all resulted in Ia-positive kidney
preparations. Many Ia antisera, and many individual Ia specific-
ities, were specifically absorbable, although monospecific sera
against Ia 7, 8, and 9 were most frequently used. Ia in kidney
exceeded that in whole blood, and was not reduced when 90% of
the blood was removed by perfusion. Thus, Ia in kidney is on
cells resident in kidney, rather than on cells in trapped blood.
Bone marrow chimeras of various types were created, in which
the marrow-derived cells were of one Ia phenotype and the non-
marrow-derived cells were of another. In such animals two
sources of Ia could be demonstrated in kidney: Ia of bone-mar-
row-donor type, and Ia of nonbone-marrow-donor type. Thus, Ia
in mouse kidney is present on resident cells, and is derived in
part from bone-marrow-derived cells (passenger leukocytes),
and in part from nonbone-marrow-derived cells, which may be
endothelial cells, renal tubular cells, etc.
Coated-charcoal hemoperfusion for drug intoxication. R. Hons,
B. Pate!, H. Mandin, and K. Taub. Faculty of Medicine, Univer-
sity of Calgary, and Department of Medicine, Foothills Hospi-
tal, Calgary, Alberta. Coated activated charcoal hemoperfusion
(CACH) is advocated for patient detoxification. It complements
other supportive measures and may diminish complications in
the Intensive Care Unit (ICU). Since January 1976, we have per-
formed 15 hemoperfusions on 13 intoxicated patients using acryl-
ic hydrogel and cellulose coated activated charcoal columns.
Seven drug group intoxications occurred. Ages ranged from 1.6
to 74 years. Twelve patients survived; one died. Data on all pa-
tients was reviewed, and six were satisfactory for calculation of
column clearances.
Initial
plasma
Clearance, mi/mm
— Clinical
level Max. coma &
jig/mi (QB)* Average result
Amobarbital 11 144
(200)
113 IV
Survived
Phenobarbital 265 110
(175)
70 IV
Survived
Propoxyphene 1.6 71
(200)
67 IV
Died
Amitriptyline 1.1 111
(250)
59 IV
Survived
Imipraminet 0.7 50
50)
50 IV
Survived
Glutethimide 13 111
(200)
107 IV
Survived
* QB—Blood flow ml/min.
t Age—1.6 years.
We believe that CACH significantly contributes to the ICU sup-
portive measures for detoxification. Improved biocompatible
coating membranes should enhance hemoperfusion efficacy.
Blood transfusion and graft survival in 100 cadaveric kidney
transplants. P. A. Keown, B. Lockwood, C. R. Stiller, and R. A.
Ulan. Division of Nephrology and Transplantation, University
Hospital, U. W.O., London, Ontario. The role of blood trans-
fusion (TR) in kidney transplantation is of considerable clinical
importance. We have evaluated a series of 100 consecutive non-
diabetic first cadaveric transplants to elucidate the influence of
TR prior to or during surgery upon graft survival, the number
and severity of rejection episodes (RE) and their response to
therapy. Transfusion prior to transplantation (P) was associated
with excellent 12-month graft survival (73%) differing significant-
ly from that in the nontransfused group (44%) (P <0.025). Trans-
fusion during surgery (D) had no significant beneficial or detri-
mental effect on ultimate graft survival (D = 47%) (P + D =
67%). No correlation was found between the number of TR and
graft survival (r =
—0.183) or the TR/TX interval (r = 0.37).
Maximum allograft attrition occurred within the first 100 days in
all groups. In those grafts achieving immediate function, the
mean incidence of RE was lower in the TR than non-TR group
(1.8 vs. 3) and the number of patients experiencing less than 2 RE
was significantly different, (P < 0.025). No significant difference
in severity of rejection (1.6/3 vs. 1.6/3) or response to therapy
was observed between the groups. Conclusion. Blood trans-
fusion prior to, but not during, renal transplantation is associated
with significantly superior allograft survival. The severity of RE
and response to therapy is independent of prior TR, but the de-
creased frequency of RE in the transfused group results in im-
proved graft survival.
Continuous ambulatory peritoneal dialysis in diabetics. R.
Khana, D. G. Oreopoulos, W. McCready, L. Chisholm, B. Lei-
be!, and G. Blair. Department of Medicine, Ophthalmology, To-
ronto Western Hospital, Toronto, Ontario, Canada. Eight men
and three women, insulin-dependent diabetics of mean duration
of 24.5 yr with end-stage renal disease (ESRD), were treated
with continuous ambulatory peritoneal dialysis (CAPD) for 119
patient months (range, 2 to 22 mos). Mean age was 43.3 yr. Blood
sugar was controlled by three different regimens of regular in-
sulin administration: (a) subcutaneous injection (SC), (b) intra-
peritoneal (IP) with every dialysis bag, (c) combination of SC and
IP. There have been no deaths in the series. Eight pts are contin-
uing on CAPD. Three pts received kidney transplantation. Either
alone or in combination with SC, IP administration of insulin,
satisfactory blood sugar control was achieved. (Mean blood sug-
ars: fasting 130.3 67.4, 1 hr before breakfast 179.8 68.6, and
lunch 135.8 68.6). Uremia was adequately controlled (BUN,
64.8 18.3). Motor nerve conduction velocity was unchanged in
5 and progressed in 2. Visual acuity improved in 4, remained
unchanged in 2, and deteriorated in 1. Rate of peritonitis was one
episode every 14.9 pt-months. Other complications are hypoten-
sion in 2 and obesity in 1. Hypertension was controlled in all
without antihypertensive medication. Conclusion. CAPD holds
promise as an effective treatment for diabetic ESRD because in-
sulin added in appropriate dosage to the dialysate controls the
blood sugar as well as fluid and electrolyte balance and also hy-
pertension. While it is apparent that life is prolonged, there is no
evidence of remission of degenerative disease.
Utilization of ketone bodies by the normal and diabetic kidney: In
vitro studies in the rat. G. Lemieux, M. Achkar, P. Vinay, and A.
Gougoux. Renal Laboratory, Hôtel-Dieu Hospital and Dept. of
Medicine, University of Montreal, Montreal, Quebec. Renal cor-
tical slices from Wistar rats were incubated (pH, 7.4) with either
betahydroxybutyrate or acetoacetate at concentrations of I and 5
mM. Diabetes mellitus was induced by injecting streptozotocin
150 mg/kg in the tail vein. Two groups of diabetic rats were stud-
ied; one treated with insulin and one which was allowed to devel-
op ketoacidosis. In the latter plasma bicarbonate dropped from
28.9 to 13.2 mmoles/liter. In normal control rats, betahydroxy-
butyrate uptake averaged 10.8 moles/g wet weight/hr, and ace-
toacetate was 14.4 at 1 m of each substrate. These values were
not different in diabetic rats treated with insulin. Metabolic acid-
osis (NH4CI) or alkalosis (furosemide) gave similar results. It
was possible to demonstrate that kidney tissue transforms part of
total uptake of betahydroxybutyrate into acetoacetate and vice
versa. Renal uptake of ketone bodies was 30 to 40% lower in
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diabetic rats with ketoacidosis but total uptake of betahydroxy-
butyrate or acetoacetate was converted to the other ketone.
These studies indicate that the diabetic kidney in the absence of
ketoacidosis is able to utilize ketone bodies in a normal fashion.
In diabetic rats with ketoacidosis the renal uptake of ketones is
diminished and the kidney is unable to oxidize ketone bodies.
Some of our data also suggest that the diabetic kidney may par-
ticipate in ketogenesis during ketoacidosis.
Variable heparin requirements during dialysis. R. M. Lindsay,
W. F. Clark, and A. L. Lint on. University of Western Ontario,
London, Canada. Heparinization cannot be gauged on a body
weight basis and there is intersubject variation in requirements.
Also, a subject may change his dialysis heparin requirements
with time. These observations have prompted the claim that
heparin may have variable potency. The argument will be pre-
sented that this claim is false and that variability rests with the
patient. The following aspects will be considered: (1) Thrombus
formation during dialysis can take place in spite of adequate he-
parinization (based upon scanning electromicroscopic observa-
tions). (2) The platelet-foreign surface interaction is of impor-
tance in such thrombus formation (based upon observations of
post-dialysis thrombocytopenia, platelet retention on dialysis
membranes and the results of a double blind trial involving anti-
platelet agents). (3) The role of heparin upon the platelet-foreign
surface interaction (in vitro studies demonstrate that heparin in
solution in concentrations of 4 s/ml enhance platelet retention by
dialysis membranes while irreversible heparin bonding blocks
platelet retention). (4) The effect of platelet release upon heparin
therapy. (During the release reaction platelet factor 4, PF4, is re-
leased which confers heparin neutralizing activity, HNA, to
plasma. Plasma HNA levels have been found to be high in dia-
lyzed uremics and to correlate with heparin requirements.) (5)
The effect of dialysis upon platelet release. (Treatment of ure-
mics by dialysis improves platelet function and enhances PF4 re-
lease). The interrelationship of these will be discussed and a logi-
cal policy for anticoagulation suggested.
Adaptation to home dialysis: Remodialysis vs. continuous am-
bulatory peritoneal dialysis. R. M. Lindsay, D. Oreopoulos, H.
Burton, P. Conley, G. Wells, and A. L. Linton. Dept. of Medi-
cine, Universities of Western Ontario and Toronto, and Health
Care Research Unit, University of Western Ontario, London,
Ontario. Studies were made retrospectively on 232 patients on
home dialysis from 16 centers in Ontario with a view to assessing
adaptation to the dialysis mode employed. One hundred forty-
nine patients were managed by hemodialysis (H), eighty-three by
continuous ambulatory peritoneal dialysis (CAPD). Significant
differences (P < 0.05 or better) were found between H and
CAPD in physical and psychosocial aspects. CAPD patients had
less training time, lower plasma protein concentrations and, at 6
months, higher hemoglobin levels, but not at 1 year. H patients
had a lower hospital readmission rate. CAPD interfered more
with work and reduced the ability to return to employment espe-
cially in males. H was associated with more stresses (related to
dialysis) and concerns (related to life) and this was especially
marked in the young female. Basic Personality Inventory (BPI)
scores for depression, anxiety, self deprecation, social in-
troversion, and denial were higher than a control population but
were not influenced by dialysis mode. A positive correlation be-
tween BPI scores and stresses and concerns were noted, except
with denial which had an inverse correlation. Decisions about
types of therapy to be offered to patients with end-stage renal
disease are presently usually based on age, clinical status and
national habits; this data suggests that matching of treatment to a
life style and personality analysis might lead to improved adapta-
tion.
Randomized clinical trial of cephalexin in preventing peritonitis
in patients on continuous ambulatory peritoneal dialysis. D. E.
Low, S. Vas, D. G. Oreopoulos, A. Manuel, C. Saiphoo, C. Fin-
er, N. Dombros, and M. Leung. Toronto Western Hospital and
Sunnybrook Medical Centre, Toronto, Canada. Continuous am-
bulatory peritoneal dialysis (CAPD) is becoming a feasible alter-
native mode of therapy for patients with end-stage renal disease.
However, the many advantages of this method of dialysis have
been offset by the frequent occurrence of peritonitis. Over 60%
are due to either Staphylococcus aureus or S. epidermidis. To
determine the efficacy of prophylactic cephalexin in reducing the
incidence of peritonitis in patients on CAPD, we randomized 50
patients to either a treatment (T) group (25 patients), who re-
ceived 500mg per os of cephalexin BID, or to a control (C) group
(25 patients) who received a placebo. The T patients remained on
the study for an average of 14 (2 to 27) wks (350 patient-wks)
while the C patients remained on the study for an average of 12.8
(1 to 27) wks (320 patient-wks). We randomly selected 20 pa-
tients (11 T, 9 C) for serum (S) and dialysate (D) cephalexin lev-
els. The peak mean S and D levels in T group were 50.7 g/ml
and 13.2 sWml. Nine episodes of peritonitis occurred in 9 pa-
tients in the T group (one every 39 patient-wks) compared to 7
episodes of peritonitis in 6 patients in the C group (one every 46
patient-wks). Of the 12 organisms isolated in the T group, 8
(67%) were resistant to cephalexin compared to only 3 of 9 (33%)
in the C group. Conclusion. Prophylactic oral cephalexin does
not prevent peritonitis in patients on CAPD and may enhance
selection of resistant organisms.
Enhancement of renal allografts by presensitization to public
"Ia" antigens. R. P. Lowry and C. B. Carpenter. Peter Bent
Brigham Hospital, Boston, Massachusetts. Although 8 DR spec-
ificities have been defined in man, it now appears that all com-
mon DR specificities fall into three supertypic (public) groups:
MTI, 2, and 3. Accordingly, we have examined the role of public
La antigens in a rat experimental renal transplant model. Pre-
immunization of LEW hosts with BUF lymphoid cells produced
significant prolongation (P < 0.005 by log rank) of survival of
allografts taken from a third party, (LEWxBN)F1. Serologic
analysis demonstrated that BN and BUF share an MHC encoded
public Ia specificity, expressed on B cells, which was call Ia 15.
Hyperimmune sera directed at this specificity are cytotoxic to 20
3% of lymph node cells, significantly inhibit the formation of
EA rosettes by Fc receptor bearing cells and inhibit MLR by 50-
60% when directed at the stimulator but not responder strain
cells. Study of many hyperimmune sera raised between inbred
rat strains, by EAT and CDC has revealed broad patterns of
cross-reactivity, suggesting that public Ia specificities are both
complex and immunogenic. A chart of public and private "Ia"
specificities follows:
LEWRT1' 1 — — — — — —
F344 RT11' 1 — — — 14 — —
WFRT1" — 2 — — 14 — 16
BNRT1 — — 3 — 14 15 —
BUFRTI5 — — — 6 — 15 16
Though it has been considered unlikely that improved (30 to
50%) renal allograft survival induced by a single transfusion
might result by induction of antibody to the private DR specifici-
ty of a random kidney donor, it may represent active enhance-
ment by antibody to public IA specificities.
Studies in dialyzer reuse. M. A. Manuel, W. Gentles, C.
Saiphoo, and L. Braganza. Sunnybrook Hospital, University of
Toronto, Toronto, Ontario. The aim of this study was to deter-
mine whether an automatic dialyzer reuse machine (ADRM)
would clean dialyzers efficiently enough to be reused 3 or 4
times. Only hollow fiber dialyzers were evaluated. The ef-
fectiveness of the cleaning process was determined by measuring
(1) in vivo clearances of blood urea nitrogen (BUN) and creati-
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nine (Cr) 30 mm after starting each dialysis; (2) ultrafiltration ca-
pacity, by calculating the transmembrane pressure required to
remove 1 kg of weight during a 6-hour dialysis—the data of all
the patients were grouped together according to the number of
reuses; (3) in vitro clearances of Cr, bromsulfthalein (BSP), cy-
anocobalamin (B 12) and inulin (In) using a single stirring cell
technique. The clearance was calculated by determining the rate of
disappearance of each substance according to the formula InC =
ln — DtIV. In vivo clearances of BUN decreased from 141 11
to 128 22 and Cr from 121 11 to 110 19 during the 1st and
4th use, respectively. The TMP required to remove 1 kg of
weight rose progressively with each reuse (165 53 to 207 44
mm Hg) (P <0.01). In vitro clearances did not show any changes
of clinical significance. No complication could be attributed to
the reuse procedure.
Noninhibitable activation of rabbit renal renin by rabbit and
sheep plasma. J. K. McKenzie, I. M. KcKenzie, S. L. Skinner,
and A. J. M. Stubbs. Dept. of Medicine, University of Manitoba,
Winnipeg, Manitoba, and Dept. of Physiology, University of
Melbourne, Melbourne, Australia. When ground and extracted
in the proteinase inhibitors—PMSF, 2 mM; NEM, 5 mr'i; EDTA,
5 mM; aprotinin, 200 U/mi—rabbit kidney cortical extracts con-
tain very little active renin by direct pressor bioassay in the rat.
The renin isolates as an apparent single peak on ultragel Ac44
with a mol wt of 57.000. By extracting without inhibitors and
freezing and thawing or after acidification and pepsin, we can
demonstrate 10 to 20 times as much renin activity. Activa-
tion by freezing can be prevented by inhibitors, which will also
prevent activation of circulating plasma renin by cold. Despite
the presence of inhibitors, addition of rabbit renal extract to pre-
viously acidified or untreated rabbit or sheep plasma causes acti-
vation of a large percentage of the inactive renal renin within 15
mm. Simple dilution of the extract does not cause this, and the
phenomenon still occurs with minimal extract dilution with
plasma. Angiotensinase control is excellent. Rabbit kidney renin
does not have to be secreted in an active form but could be se-
creted in an inactive form and be rapidly activated by rabbit
plasma by means of a system which is not suppressed by a range
of proteinase inhibitors. Experiments purporting to be unable to
demonstrate inactive renin in systems utilizing angiotensin gen-
eration from crude plasma substrates must be very suspect be-
cause of the likelihood of activation.
An improved immunoassay for antibasement membrane anti-
bodies. D. F. Papaioannou and J. Kiassen. Dept. of Pathology,
Medicine, Univ. of Calgary, and Dept. of Laboratories, Foot-
hills Hospital, Calgary, Alberta. The pathogenic role of anti-
bodies to the glomerular basement membrane (GBM) in Good-
pasture's Syndrome and in one form of rapidly progressive gb-
merulonephritis is well accepted. Recently a radioimmunoassay
has been developed to detect such antibodies in the circulation of
such patients but several investigators have noted a lack of cor-
relation between the results of such assays and the clinical
course, especially in cases undergoing plasmapheresis. It
seemed conceivable that certain antigens were not being tested
for. We have developed a sensitive immunoassay in which GMB
and lung basement membrane antigens are isolated, and cova-
lently linked to a solid support. Binding of serum antibodies to
these antigens is detected by means of a fluorometer using fluo-
rescein isothiocyanate-labeled antisera to IgG, IgA, and 1gM.
The complement binding capacity of the antibodies can be as-
sayed by adding a source of complement to the test and then
staining for C3. Using this assay circulating antibodies were
found in all 15 patients with biopsy or autopsy-proven disease
but not in patients with other forms of glomerulonephritis nor in
any normals. Further, the effect of repeated plasmapheresis in
two patients was as predicted. From extensive absorption stud-
ies and from clinical course it appears that at least two different
antigens are detected; one seems to be a marker for lung lesions
and the other for renal lesions. The assay is inexpensive and easy
and fast to perform.
Tobramycin disposition in continuous ambulatory peritoneal
dialysis. T. W. Paton, M. A. Manuel, and C. S. Saiphoo. Depts.
of Pharmacy and Medicine, Sunnybrook Medical Centre, Uni-
versity of Toronto, Toronto, Ontario. The disposition of tobra-
mycin (T) in 2 groups of patients on continuous ambulatory peri-
toneal dialysis (CAPD) was studied. Group 1 consisted of 6 unin-
fected patients who were given T i.v. (4 received 1.5 mg/kg and
2 received 1.1 and 1.3 mg/kg, respectively, over 1 hour). T was
measured in serum at the end of the infusion, at the midpoint,
and at end of the first-dwell period. Subsequently, both serum
and dialysate T were determined at the end of 3 dwell periods
over 24 hours. Group 2 consisted of 4 patients with clinically
mild peritonitis who received T (5 mg/liter) and cefazolin (75 mg/
liter) i.p. Serum T was measured at the end of each dwell period
for 3 days, and CAPD was continued in the usual manner. In
group 1, the T half-life was 34 hours, volume of distribution 15.2
liters, mean dialysate clearance 4.2 mI/mm, and mean total clear-
ance 8.0 mI/mm. The amount of T removed during CAPD over a
24-hour period was 20.5% of the dose administered. Peak dialy-
sate concentrations varied from 1.8 to 3.1 g/ml. Patients who
require T for extraperitoneal infection should receive a loading
dose of 1.5 mg/kg and maintenance dose of 0.75 mg/kg every 36
hours. In group 2, there was a gradual increase in serum concen-
tration with a plateau occurring after 48 hours to a mean level of
2.1 g/ml.
Tubular sodium-handling following renal microvascular ob-
struction in the dog. B. Penner and H. Fung. Dept. of Med.,
Univ. of Manitoba, Winnipeg, Manitoba. Unilateral renal micro-
vascular obstruction was produced in two groups of mongrel
dogs by the injection of either 15 (Gp 1: N = 8, causing gb-
merular obstruction) or 50 (Gp 2: N = 11, causing arteriolar
obstruction) microspheres into the renal artery. One to two
weeks postembolization, water diuresis produced by oral water
and i.v. hypotonic glucose loading was followed by isotonic sa-
line loading (40 ml/kg/90 mm). RBF was measured by EM
flowmeters. At the end of the experiment, kidneys were stalned
using alcian blue injected intraarterially in vivo. Only perfused
areas were stained. Single nephron (SN) C, was calculated by
noting the percent of stained glomeruli. In the obstructed kid-
neys in Gp 1, both Ccr and SNCcr were reduced to 18.6 1.9 mI/
mm and 42.4 4.4 nI/mm, respectively. FF was decreased to
0.16 (contralateral 0.20). In Gp 2, Cr was comparable to Gp I,
being 14.7 1.1 mI/mm. However, SNCcr was normal, being
90.6 6.6 nI/mm. FF was decreased to 0.14 (contralateral =
0.23). During water diuresis, C0 was found to be a linear func-
tion of V in both experimental and control kidneys in both
groups. Similarly, proximal nephron Na reabsorption reflected
by SN(C. — V) was linearly related to SNC during water diur-
esis as well as during saline loading. The latter resulted in a re-
duction of the slope. These findings suggest that sodium load
may be the rate-limiting factor in determining proximal and distal
Na reabsorption. Thus, changes in GFR with or without con-
comitant changes in SNGFR affects tubular Na handling mainly
through its effects on the magnitude of the sodium load.
Dialysis-related hypotension: Etiology and prevention. G. A.
Posen and R. Mikhael. Ottawa Civic Hospital, Ottawa, Ontario.
Twelve patients were studied to determine the etiology of hypo-
tension in the 1st hour of dialysis. The dialysis composition was
(in mEq/liter): Na, 135; K, 2.5; Cl, 103; Ca, 3.25; Mg, 1.5; and
acetate, 38. The patients were studied in detail including serum
acetate, pH, Pco2, and bicarbonate initially and at time of BP
fall. The patients were divided into two groups: A(4) in whom BP
fell (av. 60/0 in 40 mm) and B(8) in whom no fall in BP occurred.
In group A the studies were repeated with (a) i.v. infusion of Na
bicarb and (b) bicarb replacing acetate in dialysate. Results: (a)
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group A patients older (>65), previous MI and CHF, (b) no dif-
ference in other parameters, (c) BP in group A fell with acetate
dialysate and i.v. bicarb but was unchanged with bicarb dialy-
sate, (d) acetate levels were similar, (e) blood gas:
pHAcetate
dialysis mit 40 mm mit
Pco2 Bi
40 mm mit
carb
40 mm
Gp A 7.33 7.36 33.8 31.3 18.8* 17.5*
B 7.37 7.36 36.4 33.2 21.8* 20.3*
* not significant
pH Pco2 Bicarb
Bicarbonate i.v.
Initial 7.331 33.8 17.4
40mm 7.466 25.5 18.2
Bicarbonate dialysis
Initial 7.37 35.3 20.6
40mm 7.42 35.3 21.6
It appears a small group of elderly patients with bad hearts be-
come hypotensive within 1 hour of starting dialysis. This fall in
BP is not prevented by correcting the acid base status but is pre-
vented by replacing acetate by bicarbonate.
Normal O*mTc methylenediphosphonate bone scans in dialysis
patients with severe osteomalacia. S. Prichard, P. Barre, D.
Goltzman, M. Kaye. Div. of Nephrol., Royal Victoria Hospital
and Montreal Gen'l Hosp. McGill Univ. Montreal, Quebec.
Renal osteodystrophy (ROD) is a common and important con-
sequence of chronic renal failure. Bone scans with 5-hr bone to
soft tissue ratios using technetium 99 methylenediphosphonate
(99mTc MDP) have been advocated as a noninvasive, simple test
to diagnose significant ROD. We now report 4 dialysis patients
with severe, biopsy-proven osteomalacia in whom the bone scan
ratios were normal. The patients were 2 males, 2 females and
range in age from 26 to 63 years (mean 43 yr). All had been on
hemodialysis from 18 months to 8 years. They all had normal
parathyroid hormone (PTH) levels and became repeatedly hy-
percalcemic on very small doses of various forms of vitamin D
therapy. There were no diagnostic radiological abnormalities.
Their symptoms included bone pain (3), fractures (3), and proxi-
mal myopathy (2). Iliac crest bone biopsies were done and quan-
titated on all 4 patients within one month of the bone scan. All
had greater than 60% bone surface ostoid without evidence of
hyperparathyroidism. The 5-hr bone scan ratios ranged from 2.2
to 5.5 (upper limit of normal 5) with a mean of 3.8 1.2. We
conclude that dialysis patients with pure osteomalacia, even
when very severe, may have normal bone scans (contrary to pre-
vious observations). Therefore, bone biopsy remains the only ac-
curate diagnostic test to assess the severity, extent, and type of
bone disease in renal failure patients.
HLA typing in benign familial hematuria and Alport's syn-
drome. D. P. S. Sengar, A. Rashid, R. A. Couture, and N. M.
Wolfish. Ottawa Gen. Hosp. and Univ. of Ottawa, Ottawa, On-
tario. Genetic features of hereditary nephritis are complex and
the mode of inheritance has been variously reported. We have
tissue typed four families (20 subjects) with benign recurrent
hematuria and three families (16 subjects) with Alport's syn-
drome to see linkage with HLA complex. Families had been fol-
lowed for 5 to 10 years. In the families with benign hematuria, all
affected siblings (11) and affected parents (4) had normal renal
function. In the families with Alport's syndrome, 3 out of 5 male
siblings were affected and had abnormal renal function. HLA
typing for HLA-A and -B series was performed using standard
complement-dependent lymphocytotoxicity test. No apparent
association was observed between HLA haplotype and Alport's
syndrome. Although our data in all families with benign hema-
tuna were compatible with x-linked inheritance, yet a possibility
of an autosomal linkage with HLA complex could not be ruled
out. No single HLA halotype was associated with benign hema-
tuna. However, all affected siblings within a family were HLA
identical and the ratio of affected to unaffected siblings for famil-
iar hematuria was 11 to 1. Our results of present study may have
been biased as only those families were HLA typed where one of
the parents had a history and clinical symptoms of benign hema-
tuna. The complete segregation of benign hematuria with HLA
in these families appears interesting and should be further as-
sessed to illucidate the role of HLA haplotype, if any, in the
expression of benign hematuria.
Effect of altered sodium balance on vascular responsiveness to
angiotensin II and norepinephrine in the rat. D. Smyth and H.
Fung. Dept. of Pharmacol. & Therap., Univ. of Manitoba, Win-
nipeg, Manitoba. In vivo pressor responses to graded iv. All in-
fusion were significantly increased in animals placed on a high
sodium diet as compared to those on a low sodium diet. Respon-
siveness to norepinephnne (NE) was unchanged. Following iv.
captopril (0.3 mg/kg), mean arterial BP fell by 10.7 4.7 mm Hg
only in the low salt group, with a shift to the All pressor response
to the left. The dose of All required to cause a 50-mm-Hg increase
in BP was reduced from 0.7 to 0.2 g/kg/min. Dose response to All
in high salt group remained unchanged. This was in contrast to
the dose-response to NE where no shifts occurred in either
group. Shifts in pressor responsiveness to All were not observed
during i.v. nitroprusside, or during acute 3% body wt isotonic
volume expansion in the low salt rat. In the isolated kidney per-
fused with Krebs-Henseleit solution, increased responsiveness
to All was observed in kidneys from high salt animals (ED5O =
4.5 x 10°g/ml) as compared to those from low salt animals (ED50
= 9 x 109g/ml). This shift was not observed for NE. These re-
sults showed that changes in sodium balance can affect the pres-
sor responsiveness and vascular reactivity to All. In vivo pres-
sor responsiveness is dependent in part on the endogenous levels
of All. However, enhanced in vitro renovascular responsiveness
to All in the high-salt rats further suggests that other factors such
as increased in All receptor number and/or affinity should also
be considered.
Use of amiloride to study distal nephron hydrogen ion secretion
in the dog. S. C. Tam, A. Gougoux, P. Vinay, G. Lemieux, M. A.
Duran, M. B. Goldstein, B. J. Stinebaugh, and M. L. Halperin.
Univ. of Toronto, Toronto, Canada, Univ. of Montreal, Montre-
al, Canada, and Baylor College of Medicine, Houston, Texas.
The purpose of this study was to evaluate physiologic factors
influencing distal hydrogen ion secretion (DNHS). We have
shown that DNHS is stimulated to two processes; first, in dogs
with a normal ECF volume, distal sodium delivery and avidity
are the primary determinants of DNHS; second, in dogs with an
expanded ECF volume, DNHS is influenced by the urine bi-
carbonate concentration (UBIC). In normovolemic dogs, amilo-
ride (AM) (a drug which inhibits sodium reabsorption in the DN)
causes the U-B Pco2 to fall from 62 7 mm Hg to 5 1 mm Hg
at comparable UBIC (62 4 and 52 2 mEq/liter); in the presence
of AM, there is a correlation between U-B Pco2 and UBIC (U-B
Pco2 = 0.18 UBIC — 14, r = 0.76). In contrast, in hypervolemic
dogs, the U-B Pco2 fell slightly with AM (10 mm Hg at a U =
200 mM). The U-B Pco2 remained strongly dependent on UBIC
before (U-B Pco2 = 0.19 UBIC + 5, r = 0.86) and after AM (U-B
Pco2 = 0.26 UBIC — 26, r = 0.75). There was a direct correlation
between U-B PCOS/UB!C and the blood [WI both before (U-B
Pcos/UHCO = 0.046 [WI — 0.87, r = 0.86) and after AM (U-B
PCOlUco, = 0.023 [HJ — 0.36, r = 0.72). Conclusion. The U-B
Pco2 is directly related to Na reabsorption and is sensitive to AM
when the ECF volume is normal. During ECF volume expan-
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sion, U seems to influence DNHS and this process is stimu-
lated by acidemia and no longer sensitive to AM.
Case report of pancreatitis associated with acute dialysis-in-
duced manganese toxicity. P. A. Taylor, and J. D. E. Price. Van-
couver General Hospital, Vancouver, B.C. A single case is pre-
sented in which there was a temporal relationship between acute
manganese (Mn) toxicity and pancreatitis. This is, we believe,
the first recorded case of acute Mn toxicity in a human. A 48-
year-old East Indian female on hemodialysis since May 1978 for
chronic renal failure secondary to polycystic kidney disease had
an uneventful course apart from her requirement for a bicarbo-
nate dialysate. Ten minutes into a routine dialysis, the patient
developed nausea and emesis with epigastric pain. The clinical
diagnosis of pancreatitis was confirmed by subsequent hyper-
amylasemia (serum amylase, 2500 lU/liter) and by CT scan
showing pancreatic edema. Examination of the chemicals used in
the dialysate revealed contamination of the NaHCO3 with
MnSO4 at a concentration of 3.2%. The supplier was unable to
account for the contamination. The patient's serum Mn level was
25 /Lg/dl (normal 0.5 to 1.0 igJdl), but fell with subsequent dial-
yses. The clinical course was complicated by hypovolemia,
hypocalcemia and a pleural effusion, with eventual full recovery.
There were no other known precipitating factors in this patient.
Two other known precipitating factors in this patient. Two other
polycystic hemodialysis patients had serum Mn within the nor-
mal range. We cannot draw any conclusions as to the pathogene-
sis of the pancreatitis but contamination of dialysate should be
considered in similar circumstances. Although, chronic Mn tox-
icity in those exposed to Mn ore has been well described, the
clinical picture being that of a Parkinson-like syndrome, a thor-
ough literature search has failed to reveal a previous description
of acute Mn poisoning.
Predictive value of serum ferritin in patients with chronic renal
failure. B. Unikowsky, N. K. M. de Leeuw, T. Hutchinson, S.
Prichard, P. Barre, and D. Hollomby. University Clinic, Royal
Victoria Hospital, McGill University, Montreal, Canada. To test
the hypothesis that a low serum ferritin (SF) is a good predictor
of deficient iron stores in patients with chronic renal failure
(CRF), we compared stainable bone marrow hemosiderin con-
comitantly with SF levels (assay method of Addison as modified
by Miles) in 39 patients with CRF (hemodialysis 28, peritoneal
dialysis 1, advanced renal fallure not on dialysis 10). Of 8 pa-
tients with 0 or trace hemosiderin, 8 had an SF level of 30 ng/ml
or less (range 2 to 30). The 31 patients with  1 + iron stores had
SF levels ranging from 75 to 560 ng/ml.
Bone marrow hemosiderin
0 or trace I + Totals
SF 3075 80 031 831
Totals 8 31 39
Since no patients had SF values between 30 and 75 ng/ml, the
predictive accuracy of these intermediate values could not be
determined. However, a value of 30 ng/ml had an accuracy of
100% in predicting iron deficiency and a value of 75 ng/ml had
an accuracy of 100% in ruling out iron deficiency. We conclude
that SF is a good indicator of deficient iron stores and may be a
useful noninvasive guide to iron replacement therapy.
Isolation of a pure suspension of rat proximal kidney tubules. P.
Vinay, G. Lemieux, and A. Gougoux. Renal Laboratory, Hotel-
Dieu Hospital, and Department of Medicine, University of Mon-
treal, Montreal, Quebec. A suspension of cortical tissue frag-
ments prepared by collagenase digestion of renal cortex obtained
from fed and chronically acidotic (NH4C1) rats was separated in
four bands on a PERCOLL density gradient. By microscopic ex-
amination, vital staining with trypan bleu, and histologic staining
technique (PAS), the band F4 was shown to contain only
(>98%) proximal tubules, while the band F1 was signifi-
cantly enriched ("70%) with distal tubules with contami-
nation by glomeruli, and short segments of proximal tubules.
Intralextracellular ratios for PAH of 15 were measured with the
F4 band and of 2 in F1 band. ATP was 1.4 smoles/g and 2.8
&moles/g in the F4 and F1 band respectively and was stable for at
least 60 mm. A F4/F1 activity ratio for the proximal cytoplasmic
phosphoenolpyruvate carboxykinase enzyme of 2.63 and 4.29
was observed in normal and acidotic rats, respectively. In con-
trast, a F4/F1 ratio of 0.12 and 0.22 was observed for the distal
cytoplasmic hexokinase enzyme. The proximal F4 band was
shown to be gluconeogenic (L-glutamine or L-lactate 2.5 m as
substrates) and to adapt to metabolic acidosis. The distal F1 band
was shown to be glycolytic (glucose, 2.5 mM) with no changes
with acid base status. All fractions were shown to metabolize
glutamine, but the metabolic fate of this amino acid was different
in proximal and distal structures. This preparation therefore al-
lows to study the metabolism of an homogeneous population of
proximal tubular fragments, and can be used to obtain some in-
formation of the enzyme location within the nephron.
Percutaneous transluminal dilatation for transplant renal artery
stenosis. C. I. Whiteside, C. J. Cardella, H. Yeung, P. R. Uldall,
G. A. deVeber, and G. T. Cook. Toronto Western Hospital, To-
ronto, Ontario. The present medical and surgical treatment of
transplant renal artery stenosis (TRAS) is complicated by the
side effects of multiple drug therapy and graft loss, respectively.
The results of percutaneous transluminal dilatation (VFD), a new
approach to vascular stenosis, are given in 4 patients with
TRAS and compared to 13 patients previously treated either
surgically or medically in order to evaluate the safety and ef-
fectiveness of PTD. TRAS >80% was diagnosed by angiography
in 17 of 279 allografts. All patients had a diastolic BP> 110 and a
bruit over the graft; 6 had a 25% rise in serum creatinine due to
the stenosis. Five of the 17 received only drug therapy and all
remained hypertensive; one subsequently developed malignant
hypertension; none had graft loss. Eight patients underwent sur-
gical repair; 5 had improvement of hypertension and retained al-
lograft function: 3 developed postoperative renal artery throm-
bosis with loss of the graft. All 4 patients treated with P'FD had
severe hypertension and impairment of renal function. Post PTD
all had a significant increase in the vessel lumen, required fewer
or no hypotensive drugs and had improvement of renal function
over a I to S month followup. No significant side effects resulted
from PTD. In one patient, who had a successful surgical repair,
PTD was not possible because the severely (98%) stenotic lesion
could not be cannulated. The PTD-treated patients had no graft
loss, a lower morbidity and required less hypotensive drug thera-
py than those in the other groups. PTD may prove to be the treat-
ment of choice for TRAS.
